2 completed, 1 recruiting, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Terminated 1 |
Follow Safety and Tolerability: new trials by email Literature Review of Safety and Tolerability trials Research Report on Safety and Tolerability
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes MKP10241, Placebo - Type 2 Diabetes Mellitus (T2DM), Food Effect | Phase 2 | Recruiting | Mankind Pharma Limited | 68 | 2025-08-12 | 2025-09-29 |
| HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I) HEPLISAV-B - Hepatitis, Safety and Tolerability | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 78 | 2018-12-07 | 2022-02-08 |
| Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I) Zoster Vaccine Recombinant, Adjuvanted - Safety and Tolerability, Compare SHINGRIX Vaccine Response Rates | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 116 | 2018-12-07 | 2023-08-04 |
| PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD inhaled human insulin, Insulin Lispro (Humalog U-100) - Safety and Tolerability | Phase 2 | Terminated | Dance Biopharm Inc. | 40 | 2018-02-06 | 2019-09-13 |
Asthma (1) · Diabetes Mellitus, Type 2 (1) · Hepatitis (1) · Herpes Simplex (1) · Herpes Zoster (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Obesity (1) · Pulmonary Disease, Chronic Obstructive (1)
Pathological Conditions, Signs and Symptoms (3) · Chronic Disease (2) · Disease Attributes (2) · Immune System Diseases (2) · Pathologic Processes (2) · Body Weight (1) · Bronchial Diseases (1) · DNA Virus Infections (1) · Diabetes Mellitus (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1)
Heplisav-B (1) · Insulin Lispro (1)
National Heart, Lung, and Blood Institute (NHLBI) (2) · Dance Biopharm Inc. (1) · Mankind Pharma Limited (1)
United States (3) · Australia (1)
Christopher MT Pleyer, M.D. (2) · Stephen Hall, MBBS, FRACP (1) · Timothy S Bailey, MD (1)